NNC0581-0001

DRUG2 trials

Sponsors

Novo Nordisk A/S

Conditions

Healthy VolunteersHepatic Steatosis

Phase 1

First Human Dose Trial for a New Medication to Potentially Treat Liver Diseases

CompletedNCT05599945

Novo Nordisk A/SHealthy Volunteers, Hepatic Steatosis

Start: 2022-11-23End: 2025-08-29Updated: 2025-10-09

Multiple Dose Study for a New Medication to Potentially Treat Liver Diseases

RecruitingNCT06891365

Novo Nordisk A/SHealthy Volunteers, Hepatic Steatosis

Start: 2025-03-12End: 2027-11-15Target: 48Updated: 2026-04-07